Latest Avion Pharmaceuticals LLC Stories

2014-08-15 12:25:07

ATLANTA, Aug. 15, 2014 /PRNewswire/ -- Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and commercialization of four Captisol-enabled programs. Under the terms of the agreement, Ligand is entitled to receive an up-front payment, and is eligible to receive revenue from Captisol® material sales, potential milestone payments, and royalties on future net sales of the products...

2014-06-16 12:28:52

ATLANTA, June 16, 2014 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announces positive feedback on two New Drug Applications (NDA) with projected approvals of late 2016 and early 2017. Based on the feedback from the Food and Drug Administration (FDA) Avion will be moving into Phase II/III on one NDA Program, and into Phase II on the other. In line with Avion's strategic corporate mission, both NDAs are in the women's health category. "We are very...

2014-06-10 08:31:54

ATLANTA, June 10, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced it received the Healthcare Distribution Management Association's (HDMA's) 2014 Distribution Industry Award for Notable Achievement (DIANA) Award for the Best Manufacturer of the Year under $300 million. Honoring pharmaceuticals and consumer product manufacturer members that set the standard of excellence in new product introductions and product promotions as well as...

2014-06-04 16:25:37

ATLANTA, June 4, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced its involvement in the Jefferies 2014 Global Healthcare Conference, a four-day global meeting of healthcare industry executives and investors taking place in New York City from June 2-5, 2014. The 2014 Global Healthcare Conference draws 2,500 attendees from more than 300 participating companies and features an extensive range of public & private healthcare...

2014-04-22 08:34:17

ATLANTA, April 22, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced their business partnership with Utah based Albion® Laboratories. The collaboration will focus on the licensing of unique, patented API ingredients and future product development for Avion's women's health portfolio. Over the past 50 years, Albion® has pioneered research with unique and natural mineral delivery systems that support improvements in mineral nutrition,...

2014-03-12 08:31:21

ATLANTA, March 12, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the promotion of Mike Sullivan to the position of President. Sullivan joined Avion Pharmaceuticals in 2011 as Vice President of Sales and Marketing. Tapped for his expertise in building corporate "start-up" pharmaceutical organizations, he has been instrumental in the commercial development, infrastructure and successful launch of Avion over the past three years....

2014-01-08 08:29:15

ATLANTA, Jan. 8, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announced its recent transaction with Shawnee, Kan.-based Nephro-Tech 1, LLC, to license and market Formical® (calcium formate) on a semi-exclusive basis as part of its Prenate® Vitamin Family and women's health portfolio. Formical is a patented form of calcium also known as calcium formate. Clinical studies demonstrate that calcium formate is absorbed more rapidly, more...

Word of the Day
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.